BioCentury | Jul 24, 2014
Cover Story

It is an RNA world

...been founded to pursue lncRNAs as targets. Curna Inc....
...inhibit mRNA translation. Opko Health Inc. acquired Curna...
BioCentury | Feb 6, 2014
Tools & Techniques

RNA is for activation

...behavioral sciences at the University of Miami Miller School of Medicine . He also cofounded Curna Inc....
...commercialize a distinct single-stranded noncoding RNA-based strategy for upregulating gene expression. Opko Health Inc. acquired Curna...
BioCentury | Oct 24, 2013
Cover Story

A platform for RNA

...molecular therapeutics and adjunct professor of molecular and integrative neuroscience at Scripps Florida , cofounded Curna Inc....
...strategy for upregulating expression of therapeutically relevant proteins. In February 2011, Opko Health Inc. acquired Curna...
...and commercialization milestones for each product. At the time it was acquired by Opko Health, Curna...
BioCentury | Jul 25, 2013
Targets & Mechanisms

Silencing neuropathic pain

...least four companies have preclinical programs involving lncRNAs. These include RaNA; Isis Pharmaceuticals Inc. ; Opko-Curna...
BioCentury | Apr 19, 2012
Distillery Techniques

Technology: Drug platforms

...induce locus-specific gene expression. SciBX 5(16); doi:10.1038/scibx.2012.429 Published online April 19, 2012 Patented; licensed to Curna Inc....
BioCentury | Feb 7, 2011
Company News

Curna Inc., Opko deal

...in cash. Curna's AntagoNAT drug discovery platform up-regulates therapeutic proteins through interference with non-coding RNAs. Curna...
...out of and subsequently licensed the technology from the Scripps Research Institute. Opko Health said Curna...
...molecules which increase the production of key proteins involved in a "large number" of diseases. Curna Inc....
Items per page:
1 - 6 of 6
BioCentury | Jul 24, 2014
Cover Story

It is an RNA world

...been founded to pursue lncRNAs as targets. Curna Inc....
...inhibit mRNA translation. Opko Health Inc. acquired Curna...
BioCentury | Feb 6, 2014
Tools & Techniques

RNA is for activation

...behavioral sciences at the University of Miami Miller School of Medicine . He also cofounded Curna Inc....
...commercialize a distinct single-stranded noncoding RNA-based strategy for upregulating gene expression. Opko Health Inc. acquired Curna...
BioCentury | Oct 24, 2013
Cover Story

A platform for RNA

...molecular therapeutics and adjunct professor of molecular and integrative neuroscience at Scripps Florida , cofounded Curna Inc....
...strategy for upregulating expression of therapeutically relevant proteins. In February 2011, Opko Health Inc. acquired Curna...
...and commercialization milestones for each product. At the time it was acquired by Opko Health, Curna...
BioCentury | Jul 25, 2013
Targets & Mechanisms

Silencing neuropathic pain

...least four companies have preclinical programs involving lncRNAs. These include RaNA; Isis Pharmaceuticals Inc. ; Opko-Curna...
BioCentury | Apr 19, 2012
Distillery Techniques

Technology: Drug platforms

...induce locus-specific gene expression. SciBX 5(16); doi:10.1038/scibx.2012.429 Published online April 19, 2012 Patented; licensed to Curna Inc....
BioCentury | Feb 7, 2011
Company News

Curna Inc., Opko deal

...in cash. Curna's AntagoNAT drug discovery platform up-regulates therapeutic proteins through interference with non-coding RNAs. Curna...
...out of and subsequently licensed the technology from the Scripps Research Institute. Opko Health said Curna...
...molecules which increase the production of key proteins involved in a "large number" of diseases. Curna Inc....
Items per page:
1 - 6 of 6